1. Home
  2. OSPN vs BNTC Comparison

OSPN vs BNTC Comparison

Compare OSPN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$10.55

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.75

Market Cap

420.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
BNTC
Founded
1991
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
420.3M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
OSPN
BNTC
Price
$10.55
$11.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$16.67
$27.67
AVG Volume (30 Days)
550.2K
183.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.86%
N/A
EPS Growth
28.77
80.94
EPS
1.88
N/A
Revenue
$243,180,000.00
N/A
Revenue This Year
$3.12
N/A
Revenue Next Year
$3.42
N/A
P/E Ratio
$5.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.16
$9.85
52 Week High
$18.13
$17.15

Technical Indicators

Market Signals
Indicator
OSPN
BNTC
Relative Strength Index (RSI) 40.58 51.44
Support Level $10.26 $11.30
Resistance Level $11.68 $12.75
Average True Range (ATR) 0.41 0.77
MACD 0.02 0.18
Stochastic Oscillator 31.75 45.16

Price Performance

Historical Comparison
OSPN
BNTC

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: